Trial Profile
Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Pharmacodynamics
- 15 Jun 2018 Status changed from active, no longer recruiting to completed.
- 09 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.